- Home
- EHC vs ICLR Comparison
EHC vs ICLR Comparison
Compare EHC & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EHC | ICLR |
|---|---|---|
| Founded | 1983 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.4B | 14.3B |
| IPO Year | 1986 | 1998 |
Fundamental Metrics
Financial Performance| Metric | EHC | ICLR |
|---|---|---|
| Price | $106.96 | $186.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | $141.88 | ★ $201.23 |
| AVG Volume (30 Days) | 762.2K | ★ 1.0M |
| Earning Date | 10-29-2025 | 10-22-2025 |
| Dividend Yield | ★ 0.71% | N/A |
| EPS Growth | ★ 27.89 | N/A |
| EPS | 5.29 | ★ 7.47 |
| Revenue | $5,795,600,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $11.54 | N/A |
| Revenue Next Year | $8.78 | $0.76 |
| P/E Ratio | ★ $20.23 | $25.41 |
| Revenue Growth | ★ 11.13 | N/A |
| 52 Week Low | $87.85 | $125.10 |
| 52 Week High | $127.99 | $228.29 |
Technical Indicators
Market Signals| Indicator | EHC | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 27.57 | 59.73 |
| Support Level | $105.71 | $178.80 |
| Resistance Level | $117.50 | $188.99 |
| Average True Range (ATR) | 2.28 | 7.59 |
| MACD | -0.54 | 1.34 |
| Stochastic Oscillator | 10.61 | 83.07 |
Price Performance
Historical ComparisonAbout EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.